Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherrie L Perkins

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Blood|September 28, 2002
Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation indexMegan S Lim, Ann Adamson, Zhaosheng Lin, et al.
Leukemia & Lymphoma|May 31, 2012
Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia veraRoberto H Nussenzveig, Tatiana Burjanivova, Mohamed E Salama, et al.
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphomaJonathan D Tward, Charles V Cachoeira, Mohammed E Salama, et al.
Blood|November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Anne Auperin, Mary Gerrard, et al.
Journal of Hematopathology|August 12, 2009
Prognostic impact of C-REL expression in diffuse large B-cell lymphomaCholadda V Curry, April A Ewton, Randall J Olsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 studyMitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 29, 2017
Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexityChristian N Paxton, Dennis P O'Malley, Andrew M Bellizzi, et al.
Blood|December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Leukemia & Lymphoma|June 11, 2014
Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalitiesMohamed E Salama, Shouying Du, Olga Efimova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group reportMark A Lones, Sherrie L Perkins, Richard Sposto, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Blood|September 28, 2002
Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation indexMegan S Lim, Ann Adamson, Zhaosheng Lin, et al.
Leukemia & Lymphoma|May 31, 2012
Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia veraRoberto H Nussenzveig, Tatiana Burjanivova, Mohamed E Salama, et al.
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphomaJonathan D Tward, Charles V Cachoeira, Mohammed E Salama, et al.
Blood|November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Anne Auperin, Mary Gerrard, et al.
Journal of Hematopathology|August 12, 2009
Prognostic impact of C-REL expression in diffuse large B-cell lymphomaCholadda V Curry, April A Ewton, Randall J Olsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 studyMitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 29, 2017
Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexityChristian N Paxton, Dennis P O'Malley, Andrew M Bellizzi, et al.
Blood|December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Leukemia & Lymphoma|June 11, 2014
Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalitiesMohamed E Salama, Shouying Du, Olga Efimova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group reportMark A Lones, Sherrie L Perkins, Richard Sposto, et al.
Pageof 13